What Is Stage II Breast Cancer?
Feb 14, 2022
Source: Cainiu Health
Dr. Wu Xuehui
Introduction
Stage II breast cancer generally refers to a primary breast tumor measuring greater than 2 cm but less than 5 cm in diameter, accompanied by metastasis to the axillary lymph nodes—specifically, mobile, palpable lymph nodes that can be moved upon physical examination. Patients with stage II breast cancer typically have a significantly better prognosis compared to those with locally advanced or metastatic (stage IV) disease. However, this staging alone does not fully predict long-term outcomes, as prognosis remains closely tied to the effectiveness of treatment.
Breast cancer is a condition characterized by uncontrolled proliferation of breast epithelial cells under the influence of multiple carcinogenic factors. In its early stages, it commonly presents with symptoms such as a breast mass, nipple discharge, and axillary lymph node enlargement. But what defines “intermediate-stage” breast cancer? Below, we address this question.
What Is Intermediate-Stage Breast Cancer?
Intermediate-stage breast cancer generally refers to a primary breast tumor larger than 2 cm but smaller than 5 cm in diameter, accompanied by metastasis to movable (non-fixed), palpable axillary lymph nodes.
Patients diagnosed with intermediate-stage breast cancer typically have a significantly better prognosis compared to those with locally advanced or metastatic disease. However, this staging alone does not fully predict long-term outcomes, as prognosis is closely tied to treatment response and molecular characteristics—including estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) status—all of which influence the risk of recurrence and metastasis.
Upon diagnosis of intermediate-stage breast cancer, prompt surgical intervention is recommended—typically a mastectomy or lumpectomy with axillary lymph node dissection. Postoperatively, adjuvant therapies—including chemotherapy, radiotherapy, endocrine therapy, and targeted therapy—are selected based on histopathological findings and immunohistochemical profiling.
Knowledge Extension: Clinical Manifestations of Breast Cancer
1. Breast Mass
The presence of a palpable breast mass is one of the most prominent clinical signs of malignant transformation in breast epithelial cells.
2. Changes in Breast Appearance
These may include unilateral or bilateral nipple discharge, pruritus, erosion, retraction (inversion), or abnormal areolar changes. While nipple discharge often suggests a benign lesion, malignancy cannot be ruled out. Additionally, patients may develop subtle dimpling of the skin overlying the breast—resembling an “orange peel” (peau d’orange)—or “dimpling” resembling a “dimple” or “pit,” along with breast swelling or erythema.
3. Lymphadenopathy
Lymph nodes constitute a critical component of the body’s immune defense system. The axillary lymph nodes lie in close proximity to the breasts. When malignant transformation occurs in breast tissue on one side, ipsilateral axillary lymph nodes may become enlarged and palpable.
The above outlines the definition and key features of intermediate-stage breast cancer. We hope this information is helpful to you.
